Mediate Pharmaceutical products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi-based pharmaceutical manufacturer with formulation, R&D, quality and regulatory capabilities across a broad product portfolio.
Mediate Pharmaceutical products in Pakistan
Mediate Pharmaceutical Pvt Ltd has 236 medicine presentations registered in Pakistan under 111 brands, covering 89 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Cardiovascular. Its brands with the most registered strengths and packs are Epimed (Sodium valproate, Valproic acid), Tricetam (Levetiracetam), C-Prox (Ciprofloxacin) and Cefafin (Ceftriaxone). 236 products have an official DRAP price on MedInfoBase. See all 111 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Mediate Pharmaceutical (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot 148-151, Sector 24, Korangi Industrial Area, Karachi, Pakistan
- Website
- mediatepharma.com ↗
- Phone
- +92 21 35074746-7
- Official contact
- Contact page ↗
- Official company profile ↗
- Corporate source details checked
- 18 Oct 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Mediate Pharmaceutical Pvt Ltd is priced against the market
209 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Alpertan 10/160 | Amlodipine + Valsartan + Hydrochlorothiazide | 10 mg + 160 mg + 12.5 mg | Tablet | 28’s | 107452 | PKR 522.20 | PKR 18.65/tablet | 🔒 Pharma Pro |
| Alpertan 10/160 | Amlodipine + Valsartan + Hydrochlorothiazide | 10 mg + 160 mg + 12.5 mg | Tablet | 14’s | 107452 | PKR 260.28 | PKR 18.59/tablet | 🔒 Pharma Pro |
| Alpertan 5 /160 | Amlodipine + Valsartan + Hydrochlorothiazide | 5 mg + 160 mg + 12.5 mg | Tablet | 14’s | 107451 | PKR 240.39 | PKR 17.17/tablet | 🔒 Pharma Pro |
| Alpertan 5 /160 | Amlodipine + Valsartan + Hydrochlorothiazide | 5 mg + 160 mg + 12.5 mg | Tablet | 28’s | 107451 | PKR 480.76 | PKR 17.17/tablet | 🔒 Pharma Pro |
| Alto-Vas | Atorvastatin | 5 mg | Tablet | 20’s | 091051 | PKR 953.23 | PKR 47.66/tablet | No comparator |
| Amoximed | Amoxicillin | 250 mg | Capsule | 10X10'S | 034417 | PKR 625.64 | PKR 6.26/capsule | 🔒 Pharma Pro |
| Amoximed | Amoxicillin | 500 mg | Capsule | 10X10'S | 034418 | PKR 930.66 | PKR 9.31/capsule | 🔒 Pharma Pro |
| Amoximed | Amoxicillin | 125 mg/5 mL | Dry suspension | 60 ml | 037024 | PKR 56.31 | PKR 0.94/mL | 🔒 Pharma Pro |
| Amoximed | Amoxicillin | 250 mg/5 mL | Dry suspension | 60 ml | 037025 | PKR 77.42 | PKR 1.29/mL | 🔒 Pharma Pro |
| Ampicilline | Ampicillin | 500 mg | Capsule | 12's | 012450 | PKR 95.33 | PKR 7.94/capsule | 🔒 Pharma Pro |
| Ampicilline | Ampicillin | 500 mg | Capsule | 10x10's | 012450 | PKR 762.59 | PKR 7.63/capsule | 🔒 Pharma Pro |
| Ampicilline | Ampicillin | 250 mg | Capsule | 12's | 012451 | PKR 45.76 | PKR 3.81/capsule | 🔒 Pharma Pro |
| Ampicilline | Ampicillin | 250 mg | Capsule | 10x10's | 012451 | PKR 407.98 | PKR 4.08/capsule | 🔒 Pharma Pro |
| Atenocard | Atenolol | 50 mg | Tablet | 20 | 033060 | PKR 141.08 | PKR 7.05/tablet | 🔒 Pharma Pro |
| Aulga | Artesunate | 60 mg | Injection | vail | 061939 | PKR 211.16 | PKR 211.16/vial/unit | 🔒 Pharma Pro |
| Aulga | Artesunate | 120 mg | Injection | vail | 086763 | PKR 307.39 | PKR 307.39/vial/unit | 🔒 Pharma Pro |
| Aulga | Artesunate | 30 mg | Injection | vail | 086764 | PKR 110.66 | PKR 110.66/vial/unit | 🔒 Pharma Pro |
| Azi-Med | Azithromycin | 250 mg | Capsule | 10'S | 039587 | PKR 419.36 | PKR 41.94/capsule | 🔒 Pharma Pro |
| Benaphal | Cephalexin | 500 mg | Capsule | 12 | 012448 | PKR 351.93 | PKR 29.33/capsule | 🔒 Pharma Pro |
| Benaphal | Cephalexin | 250 Mg | Capsule | 12 | 012449 | PKR 179.48 | PKR 14.96/capsule | 🔒 Pharma Pro |
| Benaphal | Cephalexin | 125 mg/5 mL | Suspension | 60ml | 039585 | PKR 103.82 | PKR 1.73/mL | 🔒 Pharma Pro |
| Benaphal | Cephalexin | 250 mg/5 mL | Dry suspension | 60ml | 039586 | PKR 179.48 | PKR 2.99/mL | 🔒 Pharma Pro |
| C-Prox | Ciprofloxacin | 250 mg | Tablet | 10 | 057926 | PKR 228.76 | PKR 22.88/tablet | 🔒 Pharma Pro |
| C-Prox | Ciprofloxacin | 500 mg | Tablet | 10 | 057927 | PKR 378.32 | PKR 37.83/tablet | 🔒 Pharma Pro |
| C-Prox | Ciprofloxacin | 250 mg/5 mL | Dry suspension | 60ml | 061942 | PKR 281.55 | PKR 4.69/mL | 🔒 Pharma Pro |
| C-Prox | Ciprofloxacin | 125 mg/5 mL | Dry suspension | 60ml | 061944 | PKR 158.37 | PKR 2.64/mL | 🔒 Pharma Pro |
| C-Prox | Ciprofloxacin | 250 mg | Capsule | 10’s | 067568 | PKR 228.76 | PKR 22.88/capsule | 🔒 Pharma Pro |
| C-Prox | Ciprofloxacin | 500 mg | Capsule | 10’s | 067569 | PKR 378.32 | PKR 37.83/capsule | 🔒 Pharma Pro |
| Cal-Vastatin | Atorvastatin | 10 mg | Tablet | 10's | 047272 | PKR 179.91 | PKR 17.99/tablet | 🔒 Pharma Pro |
| Cal-Vastatin | Atorvastatin | 20 mg | Tablet | 10's | 047273 | PKR 304.46 | PKR 30.45/tablet | 🔒 Pharma Pro |
| Cal-Vastatin | Atorvastatin | 40 mg | Tablet | 10's | 047274 | PKR 505.13 | PKR 50.51/tablet | 🔒 Pharma Pro |
| Cal-Vastatin Forte | Atorvastatin | 20 mg | Tablet | 20’s | 073579 | PKR 1,029.49 | PKR 51.47/tablet | 🔒 Pharma Pro |
| Cal-Vastatin Forte | Amlodipine + Atorvastatin | 20 mg + 10 mg | Tablet | 14’s | 073579 | PKR 760.68 | PKR 54.33/tablet | 🔒 Pharma Pro |
| Cal-Vastatin Forte | Amlodipine + Atorvastatin | 10 mg + 20 mg | Tablet | 30’s | 073579 | PKR 1,498.47 | PKR 49.95/tablet | 🔒 Pharma Pro |
| Cal-Vastatin Forte | Amlodipine + Atorvastatin | 20 mg + 10 mg | Tablet | 10’s | 073579 | PKR 543.34 | PKR 54.33/tablet | 🔒 Pharma Pro |
| CAL-VASTATIN PLUS | Atorvastatin | 10 mg | Tablet | 20'S | 112780 | PKR 456.69 | PKR 22.83/tablet | 🔒 Pharma Pro |
| Cefafin | Ceftriaxone | 250 mg | Injection | 1 vial | 044104 | PKR 177.72 | PKR 177.72/vial/unit | 🔒 Pharma Pro |
| Cefafin | Ceftriaxone | 500 mg | Injection | 1 vial | 044105 | PKR 299.14 | PKR 299.14/vial/unit | 🔒 Pharma Pro |
| Cefafin | Ceftriaxone | 1 g | Injection | 1 vial | 044106 | PKR 564.85 | PKR 564.85/vial/unit | 🔒 Pharma Pro |
| Cefafin | Ceftriaxone | 1 g | Injection | 1 vial | 092715 | PKR 464.43 | PKR 464.43/vial/unit | 🔒 Pharma Pro |
| Cefafin | Ceftriaxone | 500 mg | Injection | 1 vial | 092716 | PKR 245.96 | PKR 245.96/vial/unit | 🔒 Pharma Pro |
| Cefafin | Ceftriaxone | 250 mg | Injection | 1 vial | 092717 | PKR 146.13 | PKR 146.13/vial/unit | 🔒 Pharma Pro |
| Cefolix | Cefoperazone + Sulbactam | 500 mg + 500 mg | Injection | 1 vial | 045297 | PKR 462.10 | PKR 462.10/vial/unit | No comparator |
| Cefolix | Cefoperazone + Sulbactam | 1 g + 1 g | Injection | 1 vial | 045298 | PKR 646.95 | PKR 646.95/vial/unit | No comparator |
| Cetrimate | Cetirizine | 5 mg | Tablet | 10 | 034732 | PKR 57.19 | PKR 5.72/tablet | No comparator |
| Cetrimate | Cetirizine | 5 mg/5 mL | Syrup | 60 ml | 053262 | PKR 51.47 | PKR 0.86/mL | 🔒 Pharma Pro |
| Clariset | Clarithromycin | 250 mg | Tablet | 10 | 034412 | PKR 422.32 | PKR 42.23/tablet | 🔒 Pharma Pro |
| Clariset | Clarithromycin | 500 mg | Tablet | 10 | 034413 | PKR 783.04 | PKR 78.30/tablet | 🔒 Pharma Pro |
| ClarisetSource observed | Clarithromycin | 125 mg/5 mL | Held for normalizationSource reported: Tablet · structural field conflict | 60 ml | 034414Official source ↗ | No indexed price | — | — |
| Clariset | Clarithromycin | 500 mg | Injection | vial | 061952 | PKR 140.77 | PKR 140.77/vial/unit | 🔒 Pharma Pro |
All 111 Mediate Pharmaceutical brands in Pakistan
- Alpertan 10/160 Amlodipine + Valsartan + Hydrochlorothiazide · 10 mg + 160 mg + 12.5 mg tablet
- Alpertan 5 /160 Amlodipine + Valsartan + Hydrochlorothiazide · 5 mg + 160 mg + 12.5 mg tablet
- Alto-Vas Atorvastatin · 5 mg tablet
- Amoximed Amoxicillin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Ampicilline Ampicillin · 250 mg capsule, 500 mg capsule
- Atenocard Atenolol · 50 mg tablet
- Aulga Artesunate · 120 mg injection, 30 mg injection, 60 mg injection
- Azi-Med Azithromycin · 250 mg capsule
- Benaphal Cephalexin · 125 mg/5 mL suspension, 250 Mg capsule, 250 mg/5 mL suspension
- C-Prox Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg capsule
- Cal-Vastatin Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Cal-Vastatin Forte Amlodipine + Atorvastatin, Atorvastatin · 10 mg + 20 mg tablet, 20 mg tablet, 20 mg + 10 mg tablet
- CAL-VASTATIN PLUS Atorvastatin · 10 mg tablet
- Cefafin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Cefolix Cefoperazone + Sulbactam · 1 g + 1 g injection, 500 mg + 500 mg injection
- Cetrimate Cetirizine · 5 mg tablet, 5 mg/5 mL syrup
- Clariset Clarithromycin · 250 mg tablet, 500 mg tablet, 500 mg injection
- D-Sone Dexamethasone · 4 mg injection
- Decsazone Dexamethasone · 0.5 mg tablet
- Delomat Desloratadine · 2.5 mg tablet
- Diazomil Diazepam · 10 mg tablet, 10 mg/2 mL injection, 5 mg tablet
- Dok-C-M Doxycycline · 100 mg capsule
- Domprog Domperidone · 10 mg tablet, 5 mg/5 mL suspension
- Epimed Sodium valproate, Valproic acid · 250 mg tablet, 500 mg tablet
- Erthromed Erythromycin · 125 mg/5 mL suspension, 200 mg/5 mL suspension
- Ezemox Moxifloxacin · 400 mg tablet, 400 mg/250 mL infusion
- Fensid Sulfadoxine + Pyrimethamine · 500 mg + 25 mg tablet, 500 mg + 25 mg/5 mL suspension
- Gentamed Gentamicin · 80 mg injection
- Gliclamed Gliclazide · 80 mg tablet
- Glucomate Metformin · 500 mg tablet
- H –Cortisone Hydrocortisone · 100 mg injection, 250 mg injection, 500 mg injection
- Helisart Telmisartan · 40 mg tablet, 80 mg tablet
- Helisart-HC Telmisartan · 40 mg tablet
- Hilixophin Ceftriaxone · 2 g injection
- Hispan Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
- Hispan DS Cefixime · 200 mg/5 mL suspension
- Inzolir Cefazolin · 1 g injection, 250 mg injection, 500 mg injection
- Katromin Ketamine · 50 mg/mL injection
- Lami-Med Terbinafine · 125 mg tablet, 250 mg tablet
- Lebest Levofloxacin · 250 mg tablet, 500 mg tablet
- Levoflomed Levofloxacin · 250 mg capsule, 500 mg capsule
- Levoflomed inf /100ml Levofloxacin · 250 mg infusion
- Lignocaine Lidocaine · 2 % injection
- Locozar Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
- Lomitomed Diphenoxylate + Atropine · 2.5 mg + 0.025 mg tablet
- M – Lam Midazolam · 7.5 mg tablet
- M –Arthem 20 Artemether + Lumefantrine · 20 mg + 120 mg tablet
- M –Arthem forte Artemether + Lumefantrine · 80 mg + 480 mg tablet
- M –Gyno Clotrimazole · 2 % cream
- M –Kort Triamcinolone Acetonide · 40 mg injection
- M –Zine Silver sulfadiazine · 1 % cream
- M-Arthem 1ml Artemether · 80 mg injection
- M-Arthem dry Artemether + Lumefantrine · 15 mg + 90 mg/5 mL suspension
- M-Arthem DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
- M-D3 Cholecalciferol · 5 mg injection
- M-IS Iron · 100 mg/5 mL injection
- M-Kort Triamcinolone Acetonide · 4 mg tablet
- M-Lam Midazolam · 3 mg injection, 5 mg/5 mL injection
- M-Plate Clopidogrel · 75 mg tablet
- M-Tum Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Madeiron Iron polymaltose complex · 100 mg tablet
- Med-Berz Anastrozole · 1 mg tablet
- Meda-Quin Hydroxychloroquine · 200 mg tablet
- Medibrufen Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 400 mg tablet
- Medifenac forte Diclofenac · 75 mg tablet
- Medifenac Plus Diclofenac · 50 mg tablet
- Medifilic Iron, Iron polymaltose complex · 100 mg tablet, 100 mg capsule, 50 mg/5 mL syrup
- Medifilic –F Elemental iron + Folic acid, Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg capsule, 50 mg/5 mL + 0.35 mg/5 mL syrup
- Mediforan Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Medilorin Loratadine · 10 mg tablet
- Medimed Ferrous sulfate + Folic acid · 150 mg + 0.5 mg tablet
- Mediphenicol Chloramphenicol · 125 mg/5 mL suspension
- Mediprzole Omeprazole · 20 mg capsule
- Mediquine Chloroquine · 50 mg/5 mL syrup
- Medirax Aciclovir · 200 mg tablet
- Mediroxine Cefuroxime · 1.5 g injection, 125 mg tablet, 125 mg/5 mL suspension
- Mediroxine dry Powder Cefuroxime · 250 mg injection, 750 mg injection
- Medisartan plus Losartan · 100 mg tablet, 50 mg tablet
- Medivastin Simvastatin · 10 mg tablet
- Medivastin Plus Simvastatin · 10 mg tablet, 20 mg tablet
- Medizole Omeprazole · 20 mg tablet
- Megrital Carbamazepine · 200 mg tablet, 400 mg tablet
- Mep-Med Omeprazole · 40 mg infusion, 40 mg capsule
- MEPRILIZIDE Enalapril · 10 mg tablet
- Meprilzide Enalapril · 5 mg tablet
- Metroate Metronidazole (Benzoate), Metronidazole · 200 mg/5 mL suspension, 400 Mg tablet
- Mexodine Fexofenadine · 120 mg tablet, 180 mg tablet, 30 mg/5 mL suspension
- Mezomed Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg injection
- Nitatin Nystatin · 100000 units/mL suspension
- Odanso Ondansetron · 8 mg tablet
- Oolet Letrozole · 2.5 mg tablet
- Osta Med Oseltamivir · 75 mg capsule
- Para+CF Paracetamol + Pseudoephedrine + Chlorpheniramine · 500 mg + 60 mg + 4 mg tablet
- Para-Caffine Paracetamol · 500 mg tablet
- PARACETAMOL Paracetamol · 500 mg tablet
- Phenobarbitone Phenobarbital · 30 mg tablet
- R-Med Risperidone · 1 mg tablet, 2 mg tablet
- Rabavinex Ribavirin · 400 mg capsule
- Razepam Lorazepam · 1 mg tablet, 2 mg tablet
- S-Vid Ofloxacin · 200 mg tablet
- S-vid inf Ofloxacin · 200 mg/100 mL infusion
- Starline Sertraline · 50 mg tablet
- Tacromed Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
- Theomed Azathioprine · 50 mg tablet
- Toliken Quetiapine · 100 mg tablet, 25 mg tablet
- Tramorhage Tranexamic acid · 250 mg capsule, 250 mg/5 mL injection, 500 mg capsule
- Tricetam Levetiracetam · 100 mg solution, 100 mg/mL solution, 100 mg/mL injection
- Tricetam Oral Levetiracetam · 100 mg/mL solution
- Troll Plus Tramadol + Paracetamol · 37.5 mg + 325 mg tablet
- Valmopine 5 Amlodipine + Valsartan · 5 mg + 80 mg tablet
- Zywocid Linezolid · 600 mg tablet
Mediate Pharmaceutical: common questions
How many products does Mediate Pharmaceutical have in Pakistan?
Mediate Pharmaceutical Pvt Ltd has 236 registered medicine presentations in Pakistan, sold under 111 brands and covering 89 generic medicines.
What are the main brands of Mediate Pharmaceutical?
By number of registered strengths and packs, its largest brands are Epimed (Sodium valproate, Valproic acid), Tricetam (Levetiracetam), C-Prox (Ciprofloxacin), Cefafin (Ceftriaxone) and Helisart (Telmisartan). This is not a sales ranking.
Which therapy areas does Mediate Pharmaceutical cover?
The most products are in Anti-infectives (97), CNS & mental health (36), Cardiovascular (34), Oncology & immunology (13) and Respiratory & allergy (11).
Where can I see Mediate Pharmaceutical medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.